Development of the lipid-rich core in human atherosclerosis

Arteriosclerosis, Thrombosis, and Vascular Biology

Volumn 16, Issue 1, 1996, Pages 4-11

  Guyton, John R ^a   Klemp, Keith F ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

atherosclerosis; cholesterol; fibrous plaque; lipid core

Indexed keywords

HIGH DENSITY LIPOPROTEIN; LOW DENSITY LIPOPROTEIN;

ATHEROSCLEROSIS; ATHEROSCLEROTIC PLAQUE; CALCIFICATION; CHEMICAL ANALYSIS; HUMAN; LIPID ANALYSIS; LIPID BLOOD LEVEL; MORPHOMETRICS; NEOVASCULARIZATION (PATHOLOGY); PRIORITY JOURNAL; REVIEW;

EID: 0030024123     PISSN: 10795642     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.ATV.16.1.4     Document Type: Review

References (104)

1. Ridolfi RL, Hutchins GM. The relationship between coronary artery lesions and myocardial infarction: ulceration of atherosclerotic plaques precipitating coronary thrombosis. Am Heart J. 1977;93:468-486.
2. Davies MJ, Thomas AC. Plaque fissuring: the cause of acute myocardial infarction, sudden ischaemic death, and crescendo angina. Br Heart J. 1985;53:363-373.
3. Fuster V, Stein B, Ambrose JA, Badimon L, Badimon JJ, Chesebro JH. Atherosclerotic plaque rupture and thrombosis. Circulation. 1990;82(suppl II):II-47-II-59.
4. Guyton JR, Klemp KF. Transitional features in human atherosclerosis: intimal thickening, cholesterol clefts, and cell loss in human aortic fatty streaks. Am J Pathol. 1993;143:1444-1457.
5. Stary HC, Chandler AB, Glagov S, Guyton JR, Insull W Jr, Rosenfeld ME, Schaffer SA, Schwartz CJ, Wagner WD, Wissler RW. A definition of initial, fatty streak, and intermediate lesions of atherosclerosis: a report from the Committee on Vascular Lesions of the Council on Arteriosclerosis, American Heart Association. Arterioscler Thromb. 1994;14:840-856.
6. Hessler JR, Morel DW, Lewis LJ, Chisolm GM. Lipoprotein oxidation and lipoprotein-induced cytotoxicity. Arteriosclerosis. 1983;3:215-222.
7. Hughes H, Mathews B, Lenz ML, Guyton JR. Cytotoxicity of oxidized low density lipoprotein to porcine aortic smooth muscle cells is associated with the oxysterols 7-ketocholesterol and 7-hydroxycholesterol. Arterioscler Thromb. 1994;14:1177-1185.
8. Chisolm GM, Ma G, Irwin KC, Martin LL, Gunderson KG, Linberg LF, Morel DW, DiCorleto PE. 7-Beta-hydroperoxycholest-5-en-3-beta-ol, a component of human atherosclerotic lesions, is the primary cytotoxin of oxidized human low density lipoprotein. Proc Natl Acad Sci USA. 1994;91:11452-11456.
9. Bostrom K, Watson KE, Horn S, Wortham C, Herman IM, Demer LL. Bone morphogenetic protein expression in human atherosclerotic lesions. J Clin Invest. 1993;91:1800-1809.
10. Giachelli CM, Bae N, Almeida M, Denhardt DT, Alpers CE, Schwartz SM. Osteopontin is elevated during neointima formation in rat arteries and is a novel component of human atherosclerotic plaques. J Clin Invest. 1993;92:1686-1696.
11. O'Brien ER, Garvin MR, Stewart DK, Hinohara T, Simpson JB, Schwartz SM, Giachelli CM. Osteopontin is synthesized by macrophage, smooth muscle, and endothelial cells in primary and restenotic human coronary atherosclerotic plaques. Arterioscler Thromb. 1994;14:1648-1656.
12. O'Brien ER, Garvin MR, Dev R, Stewart DK, Hinohara T, Simpson JB. Angiogenesis in human coronary atherosclerotic plaques. Am J Pathol 1994;145:883-894.
13. Galis ZS, Sukhova GK, Lark MW, Libby P. Increased expression of matrix metalloproteinases and matrix degrading activity in vulnerable regions of human atherosclerotic plaques. J Clin Invest. 1994;94:2493-2503.
14. Davies MJ, Richardson PD, Woolf N, Katz DR, Mann J. Risk of thrombosis in human atherosclerotic plaques: role of extracellular lipid, macrophage, and smooth muscle cell content. Br Heart J. 1993;69:377-381.
15. Restrepo C, Tracy RE. Variations in human aortic fatty streaks among geographic locations. Atherosclerosis. 1975;21:179-193.
16. Katz SS, Shipley GG, Small DM. Physical chemistry of the lipids of human atherosclerotic lesions: demonstration of a lesion intermediate between fatty streaks and advanced plaques. J Clin Invest. 1976;58:200-211.
17. Bocan TM, Guyton JR. Human aortic fibrolipid lesions: progenitor lesions for fibrous plaques, exhibiting early formation of the cholesterol-rich core. Am J Pathol. 1985;120:193-206.
18. Bocan TM, Schifani TA, Guyton JR. Ultrastructure of the human aortic fibrolipid lesion: formation of the atherosclerotic lipid-rich core. Am J Pathol. 1986;123:413-424.
19. Guyton JR, Klemp KF. Development of the atherosclerotic core region: chemical and ultrastructural analysis of microdissected atherosclerotic lesions from human aorta. Arterioscler Thromb. 1994;14:1305-1314.
20. Stary HC. Evolution and progression of atherosclerotic lesions in coronary arteries of children and young adults. Arteriosclerosis. 1989;9(suppl I):I-19-1-32.
21. Guyton JR, Klemp KF. The lipid-rich core region of human atherosclerotic fibrous plaques: prevalence of small lipid droplets and vesicles by electron microscopy. Am J Pathol. 1989;134:705-717.
22. Smith EB. The relationship between plasma and tissue lipids in human atherosclerosis. Adv Lipid Res. 1974;12:1-49.
23. Smith EB, Slater RS. The microdissection of large atherosclerotic plaques to give morphologically and topographically defined fractions for analysis. Atherosclerosis. 1972;15:37-56.
24. Guyton JR, Bocan TM, Schifani TA. Quantitative ultrastructural analysis of perifibrous lipid and its association with elastin in nonatherosclerotic human aorta. Arteriosclerosis. 1985;5:644-652.
25. Khoo JC, Miller E, McLoughlin P, Steinberg D. Enhanced macrophage uptake of low density lipoprotein after self-aggregation. Arteriosclerosis. 1988;8:348-358.
26. Frank JS, Fogelman AM. Ultrastructure of the intima in WHHL and cholesterol-fed rabbit aortas prepared by ultra-rapid freezing and freeze-etching. J Lipid Res. 1989;30:967-978.
27. Guyton JR, Klemp KF, Mims MP. Altered ultrastructural morphology of self-aggregated low density lipoproteins: coalescence of lipid domains forming droplets and vesicles. J Lipid Res. 1991;32:953-962
28. Kovanen PT, Kokkonen JO. Modification of low density lipoproteins by secretory granules of rat serosal mast cells. J Biol Chem. 1991;266:4430-4436.
29. Steinbrecher UP, Lougheed M. Scavenger receptor-independent stimulation of cholesterol esterification in macrophages by low density lipoprotein extracted from human aortic intima. Arterioscler Thromb. 1992;12:608-625.
30. Xu XX, Tabas I. Sphingomyelinase enhances low density lipoprotein uptake and ability to induce cholesteryl ester accumulation in macrophages. J Biol Chem. 1991;266:24849-24858.
31. Tirziu D, Dobrian A, Tasca C, Simionescu M, Simionescu N. Intimal thickenings of human aorta contain modified reassembled lipoproteins. Atherosclerosis. 1995;112:101-114.
32. Tertov VV, Orekhov AN, Sobenin IA, Gabbasov ZA, Popov EG, Yaroslavov AA, Smirnov VN. Three types of naturally occurring modified lipoproteins induce intracellular lipid accumulation due to lipoprotein aggregation. Circ Res. 1992;71:218-228.
33. Hoff HF, Whitaker TE, O'Neil J. Oxidation of low density lipoprotein leads to particle aggregation and altered macrophage recognition. J Biol Chem. 1992;267:602-609.
34. Srinivasan SR, Yost K, Radhakrishnamurthy B, Dalferes ER Jr. Berenson GS. Lipoprotein-hyaluronate associations in human aorta fibrous plaque lesions. Atherosclerosis. 1980;36:25-37.
35. Goldstein JL, Hoff HF, Ho YK, Basu SK, Brown MS. Stimulation of cholesteryl ester synthesis in macrophages by extracts of atherosclerotic human aortas and complexes of albumin/cholesteryl esters. Arteriosclerosis. 1981;1:210-226.
36. Khoo JC, Miller E, McLoughlin P, Steinberg D. Prevention of low density lipoprotein aggregation by high density lipoprotein or apolipoprotein A-I. J Lipid Res. 1990;31:645-652.
37. Camejo G. The interaction of lipids and lipoproteins with the intercellular matrix of arterial tissue: its possible role in atherogenesis. Adv Lipid Res. 1982;19:1-53.
38. Wagner WD, Edwards IJ, St Clair RW, Barakat H. Low density lipoprotein interaction with artery derived proteoglycans: the influence of LDL particle size and the relationship to atherosclerosis susceptibility. Atherosclerosis. 1989;75:49-59.
39. Vijayagopal P, Srinivasan SR, Xu JH, Dalferes ER Jr, Radhakrishnamurthy B, Berenson GS. Lipoprotein-proteoglycan complexes induce continued cholesteryl ester accumulation in foam cells from rabbit atherosclerotic lesions. J Clin Invest. 1993;91:1011-1018.
40. Falcone DJ, Salisbury BGJ. Fibronectin stimulates macrophage uptake of low density lipoprotein-heparin-collagen complexes. Arteriosclerosis. 1988;8:263-273.
41. Musliner TA, McVicker KM, Iosefa JF, Krauss RM. Lipolysis products promote the formation of complexes of very-low-density and low-density lipoproteins. Biochim Biophys Acta. 1987;919:97-110.
42. Suits AG, Chait A, Aviram M, Heinecke JW. Phagocytosis of aggregated lipoprotein by macrophages: low density lipoprotein receptor-dependent foam-cell formation. Proc Natl Acad Sci U S A. 1989;86:2713-2717.
43. Heinecke JW, Suits AG, Aviram M, Chait A. Phagocytosis of lipase-aggregated low density lipoprotein promotes macrophage foam cell formation: sequential morphological and biochemical events. Arterioscler Thromb. 1991;11:1643-1651.
44. Chao FF, Blanchette-Mackie EJ, Tertov VV, Skarlatos SI, Chen YJ. Hydrolysis of cholesteryl ester in low density lipoprotein converts this lipoprotein to a liposome. J Biol Chem. 1992;267: 4992-4998.
45. Kruth HS. Subendothelial accumulation of unesterified cholesterol: an early event in atherosclerotic lesion development. Atherosclerosis. 1985;57:337-341.
46. Simionescu N, Vasile E, Lupu F, Popescu G, Simionescu M. Prelesional events in atherogenesis: accumulation of extracellular cholesterol-rich liposomes in the arterial intima and cardiac valves of the hyperlipidemic rabbit. Am J Pathol. 1986;123:109-125.
47. Guyton JR, Klemp KF. Early extracellular and cellular lipid deposits in aorta of cholesterol-fed rabbits. Am J Pathol. 1992;141:925-936.
48. Nievelstein PFEM, Fogelman AM, Mottino G, Frank JS. Lipid accumulation in rabbit aortic intima 2 hours after bolus infusion of low density lipoprotein. Arterioscler Thromb. 1991;11:1795-1805.
49. Nievelstein-Post P, Mottino G, Fogelman A, Frank J. An ultrastructural study of lipoprotein accumulation in cardiac valves of the rabbit. Arterioscler Thromb. 1994;14:1151-1161.
50. Kruth HS. Localization of unesterified cholesterol in human atherosclerotic lesions: demonstration of filipin-positive, oil-red-O-negative particles. Am J Pathol. 1984;114:201-208.
51. Chao FF, Amende LM, Blanchette-Mackie EJ, Skarlatos SI, Gamble W, Resau JH, Mergner WT, Kruth HS. Unesterified cholesterol-rich lipid particles in atherosclerotic lesions of human and rabbit aortas. Am J Pathol. 1988;131:73-83.
52. Chao FF, Blanchette-Mackie EJ, Chen YJ, Dickens BJ, Berlin E, Amende LM, Skarlatos SI, Gamble W, Resau JH, Mergner WT, Kruth HS. Characterization of two unique cholesterol-rich lipid particles isolated from human atherosclerotic lesions. Am J Pathol. 1990;136:169-179.
53. Chao FF, Blanchette-Mackie EJ, Dickens BF, Gamble W, Kruth HS. Development of unesterified cholesterol-rich lipid particles in atherosclerotic lesions of WHHL and cholesterol-fed NZW rabbits. J Lipid Res. 1994;35:71-83.
54. Mitchinson MJ, Ball RY, Carpenter KLH, Enright JH, Brabbs CE. Ceroid, macrophages and atherosclerosis. Biochem Soc Trans. 1990;18:1066-1069.
55. Mitchinson MJ. Insoluble lipids in human atherosclerotic plaques. Atherosclerosis. 1982;45:11-15.
56. Tangirala RK, Mahlberg FH, Glick JM, Jerome WG, Rothblat GH. Lysosomal accumulation of unesterified cholesterol in model macrophage foam cells. J Biol Chem. 1993;268:9653-9660.
57. Tangirala RK, Jerome WG, Jones NL, Small DM, Johnson WJ, Glick JM, Rothblat GH. Formation of cholesterol monohydrate crystals in macrophage-derived foam cells. J Lipid Res. 1994;35:93-104.
58. Minor L, Rothblat GH, Glick JM. Triglyceride and cholesteryl ester hydrolysis in a cell culture model of smooth muscle foam cells. J Lipid Res. 1989;30:189-197.
59. ++ antagonists and ACAT inhibitors promote cholesterol efflux from macrophages by different mechanisms, I: characterization of cellular lipid metabolism. Arteriosclerosis. 1988;8:46-56.
60. ++ antagonists and ACAT inhibitors promote cholesterol efflux from macrophages by different mechanisms, II: characterization of intracellular morphologic changes. Arteriosclerosis. 1988;8:57-67.
61. Chung BH, Tallis G, Yalamoori V, Anantharamaiah GM, Segrest JP. Liposome-like particles isolated from human atherosclerotic plaques are structurally and compositionally similar to surface remnants of triglyceride-rich lipoproteins. Arterioscler Thromb. 1994;14:622-635.
62. Brooks CJW, Harland WA, Steel G. Squalene, 26-hydroxycholesterol and 7-ketocholesterol in human atheromatous plaques. Biochim Biophys Acta. 1966;125:623-626.
63. Yla-Herttuala S, Palinski W, Rosenfeld ME, Parthasarathy S, Carew TE, Butler S, Witztum JL, Steinberg D. Evidence for the presence of oxidatively modified low density lipoprotein in atherosclerotic lesions of rabbit and man. J Clin Invest. 1989;84:1086-1095.
64. Daugherty A, Dunn JL, Rateri DL, Heinecke JW. Myeloperoxidase, a catalyst for lipoprotein oxidation, is expressed in human atherosclerotic lesions. J Clin Invest. 1994;94:437-444.
65. Carpenter KLH, Taylor SE, Ballantine JA, Fussell B, Halliwell B, Mitchinson MJ. Lipids and oxidised lipids in human atheroma and normal aorta. Biochim Biophys Acta. 1993;1167:121-130.
66. Lenz ML, Hughes H, Mitchell JR, Via DP, Guyton JR, Taylor AA, Gotto AM Jr, Smith CV. Lipid hydroperoxy and hydroxy derivatives in copper-catalyzed oxidation of low density lipoprotein. J Lipid Res. 1990;31:1043-1050.
67. Bocan TM, Brown SA, Guyton JR. Human aortic fibrolipid lesions: immunochemical localization of apolipoprotein B and apolipoprotein A. Arteriosclerosis. 1988;8:499-508.
68. Babaev VR, Dergunov AD, Chenchik AA, Tararak EM, Yanushevskaya EV, Trakht IN, Sorg C, Smirnov VN. Localization of apolipoprotein E in normal and atherosclerotic human aorta. Atherosclerosis. 1990;85:239-247.
69. O'Brien KD, Deeb SS, Ferguson MF, McDonald TO, Allen MD, Alpers CE, Chait A. Apolipoprotein E localization in human coronary atherosclerotic plaques by in situ hybridization and immunohistochemistry and comparison with lipoprotein lipase. Am J Pathol. 1994;144:538-548.
70. Valenzuela R, Shainoff JR, DiBello PM, Urbanic DA, Anderson JM, Matsueda GR, Kudryk BJ. Immunoelectrophoretic and immunohistochemical characterizations of fibrinogen derivatives in atherosclerotic aortic intimas and vascular prosthesis pseudo-intimas. Am J Pathol. 1992;141:861-880.
71. Bini A, Fenoglio JJJ, Mesa-Tejada R, Kudryk B, Kaplan KL. Identification and distribution of fibrinogen, fibrin, and fibrin(ogen) degradation products in atherosclerosis: use of monoclonal antibodies. Arteriosclerosis. 1989;9:109-121.
72. Kao VCY, Wissler RW. A study of the immunohistochemical localization of serum lipoproteins and other plasma proteins in human atherosclerotic lesions. Exp Mol Pathol. 1965;4:465-479.
73. Wilcox JN, Smith KM, Schwartz SM, Gordon D. Localization of tissue factor in the normal vessel wall and in the atherosclerotic plaque. Proc Natl Acad Sci U S A. 1989;86:2839-2843.
74. Berberian PA, Myers W, Tytell M, Challa V, Bond MG. Immunohistochemical localization of heat shock protein-70 in normal-appearing and atherosclerotic specimens of human arteries. Am J Pathol. 1990;136:71-80.
75. Kleindienst R, Xu Q, Willeit J, Waldenberger FR, Weimann S, Wick G. Immunology of atherosclerosis: demonstration of heat shock protein 60 expression and T lymphocytes bearing alpha/beta or gamma/delta receptor in human atherosclerotic lesions. Am J Pathol. 1993;142:1927-1937.
76. Hollander W, Colombo MA, Kirkpatrick B, Paddock J. Soluble proteins in the human atherosclerotic plaque: with special reference to immunoglobulins, C3-complement component, alpha 1-antitrypsin and alpha 2-macroglobulin. Atherosclerosis. 1979;34:391-405.
77. Rus HG, Niculescu F, Constantinescu E, Cristea A, Vlaicu R. Immunoelectron-microscopic localization of the terminal C5b-9 complement complex in human atherosclerotic fibrous plaque. Atherosclerosis. 1986;61:35-42.
78. Zhang Y, Cliff WJ, Schoefl GI, Higgins G. Plasma protein insudation as an index of early coronary atherogenesis. Am J Pathol. 1993;143:496-506.
79. Reynolds GD, Vance RP. C-reactive protein immunohistochemical localization in normal and atherosclerotic human aortas. Arch Pathol Lab Med. 1987;111:265-269.
80. Nakagami K, Shimazaki O, Sato R, Komine Y, Ohkuma S, Takano T. Monoclonal antibody EMR1a/212D recognizing site of deposition of extracellular lipid in atherosclerosis. Am J Pathol. 1989;135:93-100.
81. Levesque H, Girard N, Maingonnat C, Delpech A, Chauzy C, Tayot J, Courtois H, Delpech B. Localization and solubilization of hyaluronan and of the hyaluronan-binding protein hyaluronectin in human normal and arteriosclerotic arterial walls. Atherosclerosis. 1994;105:51-62.
82. Hoff HF, Heideman CL, Gaubatz JW, Scott DW, Titus JL, Gotto AM Jr. Correlation of apolipoprotein B retention with the structure of atherosclerotic plaques from human aortas. Lab Invest. 1978;38:560-567.
83. Smith EB, Massie IB, Alexander KM. The release of an immobilized lipoprotein fraction from atherosclerotic lesions by incubation with plasmin. Atherosclerosis. 1976;25:71-84.
84. Hansson GK, Seifert PS. Complement receptors and regulatory proteins in human atherosclerotic lesions. Arteriosclerosis. 1989;9: 802-811.
85. Seifert PS, Hugo F, Hansson GK, Bhakdi S. Prelesional complement activation in experimental atherosclerosis. Lab Invest. 1989;60:747-754.
86. Seifert PS, Kazatchkine MD. The complement system in atherosclerosis. Atherosclerosis. 1988;73:91-104.
87. Cooper RA. Abnormalities of cell-membrane fluidity in the pathogenesis of disease. N Engl J Med. 1977;297:371-377.
88. Small DM. Cellular mechanisms for lipid deposition in atherosclerosis. N Engl J Med. 1977;297:873-877.
89. Small DM. The Physical Chemistry of Lipids: From Alkanes to Phospholipids. New York, NY: Plenum Publishing Corp; 1986:406.
90. Adams CWM, Abdulla YH. The action of human high density lipoprotein on cholesterol crystals, part 1: light-microscopic observations. Atherosclerosis. 1978;31:465-471.
91. Abdulla YH, Adams CWM. The action of human high density lipoprotein on cholesterol crystals, part 2: biochemical observations. Atherosclerosis. 1978;31:473-480.
92. Johnson WJ, Mahlberg FH, Rothblat GH, Phillips MC. Cholesterol transport between cells and high-density lipoproteins. Biochim Biophys Acta. 1991;1085:273-298.
93. Warner GJ, Stoudt G, Bamberger M, Johnson WJ, Rothblat GH. Cell toxicity induced by inhibition of acyl coenzyme A:cholesterol acyltransferase and accumulation of unesterified cholesterol. J Biol Chem. 1995;270:5772-5778.
94. Okwu AK, Xu XX, Shiratori Y, Tabas I. Regulation of the threshold for lipoprotein-induced acyl-CoA:cholesterol O-acyltransferase stimulation in macrophages by cellular sphingomyelin content. J Lipid Res. 1994;35:644-655.
95. Bottcher CJF, Vangent CM. Changes in the composition of phospholipids and of phospholipid fatty acids associated with atherosclerosis in the human aortic wall. J Atheroscler Res. 1961;1:36-46.
96. Smith EB, Slater RS, Chu PK. The lipids in raised fatty and fibrous lesions in human aorta: a comparison of the changes at different stages of development. J Atheroscler Res. 1968;8:399-419.
97. Hannun YA, Bell RM. Functions of sphingolipids and sphingolipid breakdown products in cellular regulation. Science. 1989; 243:500-507.
98. Obeid LM, Linardic CM, Karolak LA, Hannun YA. Programmed cell death induced by ceramide. Science. 1993;259:1769-1771.
99. Jackson RL, Gotto AM Jr. Hypothesis concerning membrane structure, cholesterol, and atherosclerosis. Atheroscler Rev. 1976;1:1-21.
100. Gleason MM, Medow MS, Tulenko TN. Excess membrane cholesterol alters calcium movements, cytosolic calcium levels, and membrane fluidity in arterial smooth muscle cells. Circ Res. 1991;69:216-227.
101. Bocan TM, Mueller SB, Uhlendorf PD, Newton RS, Krause BR. Comparison of CI-976, an ACAT inhibitor, and selected lipid-lowering agents for antiatherosclerotic activity in iliac-femoral and thoracic aortic lesions: a biochemical, morphological, and morphometric evaluation. Arterioscler Thromb. 1991;11:1830-1843.
102. Steinberg D, Parthasarathy S, Carew TE, Khoo JC, Witztum JL. Beyond cholesterol: modifications of low-density lipoprotein that increase its atherogenicity. N Engl J Med. 1989;320:915-924.
103. Parthasarathy S, Rankin SM. Role of oxidized low density lipoprotein in atherogenesis. Prog Lipid Res. 1992;31:127-143.
104. Steinbrecher UP, Zhang H, Lougheed M. Role of oxidatively modified LDL in atherosclerosis. Free Radic Biol Med. 1990;9:155-168.